Dyfyniad APA

Berge, E. M., Aisner, D., & Doebele, R. C. (2013). Erlotinib response in a NSCLC patient with a novel compound G719D+L861R mutation in EGFR.

Dyfyniad Arddull Chicago

Berge, Eamon M., Dara Aisner, and Robert C. Doebele. Erlotinib Response in a NSCLC Patient With a Novel Compound G719D+L861R Mutation in EGFR. 2013.

Dyfyniad MLA

Berge, Eamon M., Dara Aisner, and Robert C. Doebele. Erlotinib Response in a NSCLC Patient With a Novel Compound G719D+L861R Mutation in EGFR. 2013.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.